623155-66-8

Upstream product

• 303133-89-3 N-cyclopropyl-4-methyl-3-nitrobenzamide 

Downstream Products

• 851772-26-4 C₂₃H₂₁N₅O₂ 
• 623152-11-4 ethyl 4-(5-(cyclopropylcarbamoyl)-2-methylphenylamino)-5-methylpyrrolo[1,2-f][1,2,4]triazine-6-carboxylate 
• 745077-97-8 3-(2-Chloroacetamido)-N-cyclopropyl-4-methylbenzamide 
• 1026765-02-5 C₂₀H₁₇ClN₄O₃ 
• 1026765-87-6 C₁₉H₁₈N₄O₃S 
• 1026764-98-6 C₂₁H₁₈ClN₃O₃ 
• 1026765-94-5 C₁₅H₁₅N₃O₂S 
• 1026766-37-9 5-(4-chlorophenyl)-N-(5-(cyclopropylcarbamoyl)-2-methylphenyl)furan-2-carboxamide 
• 1026767-68-9 N-cyclopropyl-3-(2-mercaptoacetamido)-4-methylbenzamide 

Relevant academic research and scientific papers

Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors

The invention is directed to processes for preparing 2-aminothiazole-5-carboxamides of formula I [image] wherein R1, R2, R3, R4 and R5 are as defined as set forth in the specification herein.

PHENYL-ANILINE SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS KINASE INHIBITORS

Compounds having the formula (I), and pharmaceutically acceptable salts, prodrugs, and solvates thereof, are useful as kinase inhibitors, wherein R, R1 , R2, R5, R6a, R6b, J, K, X and Z are as described in the specification.